Companies covered: InspireMD, Inc. (AMEX:NSPR), Envoy Medical Inc. (NASDAQ:COCH), NeuroPace Inc. (NASDAQ:NPCE), Stereotaxis, Inc. (NASDAQ:STXS), EDAP TMS S.A. (NASDAQ:EDAP), Boston Scientific Corporation (NYSE:BSX), Abbott Laboratories (NYSE:ABT), Johnson & Johnson (NYSE:JNJ), Silk Road Medical Inc. (NASDAQ:SILK), LENSAR Inc. (NASDAQ:LNSR), Tela Bio Inc. (NASDAQ:TELA), Elutia Inc. (NASDAQ:ELUT), Medtronic, Inc. (NYSE:MDT), iRadimed Corporation (NASDAQ:IRMD), Intuitive Surgical, Inc. (NASDAQ:ISRG), Stryker Corporation (NYSE:SYK), Alcon AG (NYSE:ALC), GE HealthCare Technologies Inc. (NASDAQ:GEHC), Hologic, Inc. (NASDAQ:HOLX), RxSight Inc. (NASDAQ:RXST), Glaukos Corp (NYSE:GKOS), Penumbra Inc. (NYSE:PEN), Globus Medical, Inc. (NYSE:GMED), Alphatec Holdings, Inc. (NASDAQ:ATEC), Tempus AI Inc. (NASDAQ:TEM), Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), Zimmer Biomet Holdings Inc. (NYSE:ZBH), DexCom, Inc. (NASDAQ:DXCM), Ekso Bionics Holdings Inc. (NASDAQ:EKSO), OraSure Technologies, Inc. (NASDAQ:OSUR), Sensus Healthcare (NASDAQ:SRTS), Xtant Medical Holdings Inc. (NYSEAMERICAN:XTNT)
